ID PO5F1_HUMAN Reviewed; 360 AA. AC Q01860; A6NCS1; A6NLL8; P31359; Q15167; Q15168; Q16422; Q5STF3; AC Q5STF4; DT 01-JUL-1993, integrated into UniProtKB/Swiss-Prot. DT 01-JUL-1993, sequence version 1. DT 13-OCT-2009, entry version 105. DE RecName: Full=POU domain, class 5, transcription factor 1; DE AltName: Full=Octamer-binding transcription factor 3; DE Short=Oct-3; DE AltName: Full=Oct-4; GN Name=POU5F1; Synonyms=OCT3, OCT4, OTF3; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND B), VARIANTS ALA-322 AND RP LEU-357, AND TISSUE SPECIFICITY. RC TISSUE=Kidney; RX MEDLINE=93027160; PubMed=1408763; DOI=10.1093/nar/20.17.4613; RA Takeda J., Seino S., Bell G.I.; RT "Human Oct3 gene family: cDNA sequences, alternative splicing, gene RT organization, chromosomal location, and expression at low levels in RT adult tissues."; RL Nucleic Acids Res. 20:4613-4620(1992). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC TISSUE=Peripheral blood leukocyte; RX PubMed=16702430; DOI=10.1534/genetics.106.057034; RA Shiina T., Ota M., Shimizu S., Katsuyama Y., Hashimoto N., Takasu M., RA Anzai T., Kulski J.K., Kikkawa E., Naruse T., Kimura N., Yanagiya K., RA Watanabe A., Hosomichi K., Kohara S., Iwamoto C., Umehara Y., RA Meyer A., Wanner V., Sano K., Macquin C., Ikeo K., Tokunaga K., RA Gojobori T., Inoko H., Bahram S.; RT "Rapid evolution of major histocompatibility complex class I genes in RT primates generates new disease alleles in humans via hitchhiking RT diversity."; RL Genetics 173:1555-1570(2006). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Shiina S., Tamiya G., Oka A., Inoko H.; RT "Homo sapiens 2,229,817bp genomic DNA of 6p21.3 HLA class I region."; RL Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055; RA Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., RA Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., RA Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R., RA Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S., RA Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J., RA Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P., RA Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y., RA Burford D.C., Burrill W., Burton J., Carder C., Carter N.P., RA Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V., RA Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J., RA Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., RA Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A., RA Frankland J., French L., Garner P., Garnett J., Ghori M.J., RA Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M., RA Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S., RA Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R., RA Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E., RA Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A., RA Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C., RA Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M., RA Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M., RA Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., RA McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., RA Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R., RA Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W., RA Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M., RA Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L., RA Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J., RA Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B., RA Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L., RA Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W., RA Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A., RA Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.; RT "The DNA sequence and analysis of human chromosome 6."; RL Nature 425:805-811(2003). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., RA Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., RA Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., RA Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R., RA Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H., RA Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G., RA Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W., RA Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Lung; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [7] RP NUCLEOTIDE SEQUENCE [MRNA] OF 188-274, AND TISSUE SPECIFICITY. RC TISSUE=Heart, and Skeletal muscle; RX MEDLINE=94192665; PubMed=7908264; RX DOI=10.1111/j.1432-1033.1994.tb18676.x; RA Wey E., Lyons G.E., Schaefer B.W.; RT "A human POU domain gene, mPOU, is expressed in developing brain and RT specific adult tissues."; RL Eur. J. Biochem. 220:753-762(1994). RN [8] RP NUCLEOTIDE SEQUENCE [MRNA] OF 212-283. RX MEDLINE=96160538; PubMed=8567814; RA Abdel-Rahman B., Fiddler M., Rappolee D., Pergament E.; RT "Expression of transcription regulating genes in human preimplantation RT embryos."; RL Hum. Reprod. 10:2787-2792(1995). RN [9] RP IDENTIFICATION. RX PubMed=16229821; DOI=10.1016/j.bbrc.2005.09.157; RA Suo G., Han J., Wang X., Zhang J., Zhao Y., Zhao Y., Dai J.; RT "Oct4 pseudogenes are transcribed in cancers."; RL Biochem. Biophys. Res. Commun. 337:1047-1051(2005). RN [10] RP INTERACTION WITH PKM2, SUBCELLULAR LOCATION, DOMAIN, AND INDUCTION. RX PubMed=18191611; DOI=10.1016/j.biocel.2007.11.009; RA Lee J., Kim H.K., Han Y.-M., Kim J.; RT "Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with RT Oct-4 in regulating transcription."; RL Int. J. Biochem. Cell Biol. 40:1043-1054(2008). CC -!- FUNCTION: Transcription factor that binds to the octamer motif CC (5'-ATTTGCAT-3'). Forms a trimeric complex with SOX2 on DNA and CC controls the expression of a number of genes involved in embryonic CC development such as YES1, FGF4, UTF1 and ZFP206. Critical for CC early embryogenesis and for embryonic stem cell pluripotency (By CC similarity). CC -!- SUBUNIT: Interacts with UBE2I (By similarity). Interacts with CC PKM2. CC -!- INTERACTION: CC Q9UJU5:FOXD3; NbExp=2; IntAct=EBI-475687, EBI-475674; CC -!- SUBCELLULAR LOCATION: Nucleus. Note=Expressed in a diffuse and CC slightly punctuate pattern. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=A; Synonyms=Oct-3A, Oct3A; CC IsoId=Q01860-1; Sequence=Displayed; CC Name=B; Synonyms=Oct-3B, Oct3B; CC IsoId=Q01860-2; Sequence=VSP_002333; CC -!- TISSUE SPECIFICITY: Expressed in developing brain. Highest levels CC found in specific cell layers of the cortex, the olfactory bulb, CC the hippocampus and the cerebellum. Low levels of expression in CC adult tissues. CC -!- INDUCTION: Transcriptional activity is positively regulated by CC PKM2. CC -!- DOMAIN: The POU-specific domain mediates interaction with PKM2. CC -!- PTM: Sumoylation enhances the protein stability, DNA binding and CC transactivation activity. Sumoylation is required for enhanced CC YES1 expression (By similarity). CC -!- MISCELLANEOUS: Several pseudogenes of POU5F1 have been described CC on chromosomes 1, 3, 8, 10 and 12. 2 of them, localized in CC chromosomes 8 and 10, are transcribed in cancer tissues but not in CC normal ones and may be involved in the regulation of POU5F1 gene CC activity in carcinogenesis. CC -!- SIMILARITY: Belongs to the POU transcription factor family. Class- CC 5 subfamily. CC -!- SIMILARITY: Contains 1 homeobox DNA-binding domain. CC -!- SIMILARITY: Contains 1 POU-specific domain. CC -!- WEB RESOURCE: Name=Wikipedia; Note=Oct-4 entry; CC URL="http://en.wikipedia.org/wiki/Oct-4"; CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; Z11898; CAA77951.1; -; mRNA. DR EMBL; Z11899; CAA77952.1; -; mRNA. DR EMBL; AB088113; BAC54946.1; -; Genomic_DNA. DR EMBL; AB202105; BAE78630.1; -; Genomic_RNA. DR EMBL; AB103619; BAF31281.1; -; Genomic_DNA. DR EMBL; BA000025; BAB63311.1; -; Genomic_DNA. DR EMBL; AL662833; CAI17407.1; -; Genomic_DNA. DR EMBL; AL662833; CAI17408.1; -; Genomic_DNA. DR EMBL; AL662844; CAI18331.1; -; Genomic_DNA. DR EMBL; AL773544; CAI18485.1; -; Genomic_DNA. DR EMBL; AL773544; CAI18486.1; -; Genomic_DNA. DR EMBL; BX088580; CAI18708.1; -; Genomic_DNA. DR EMBL; BX088580; CAI18709.1; -; Genomic_DNA. DR EMBL; CR759815; CAQ07092.1; -; Genomic_DNA. DR EMBL; CR759815; CAQ07093.1; -; Genomic_DNA. DR EMBL; CR388229; CAQ09226.1; -; Genomic_DNA. DR EMBL; CR388229; CAQ09227.1; -; Genomic_DNA. DR EMBL; CR847794; CAQ10780.1; -; Genomic_DNA. DR EMBL; CR847794; CAQ10781.1; -; Genomic_DNA. DR EMBL; CH471081; EAX03367.1; -; Genomic_DNA. DR EMBL; CH471081; EAX03368.1; -; Genomic_DNA. DR EMBL; BC117435; AAI17436.1; -; mRNA. DR EMBL; BC117437; AAI17438.1; -; mRNA. DR EMBL; Z21963; CAA79974.1; -; mRNA. DR EMBL; Z21964; CAA79975.1; -; mRNA. DR EMBL; S81255; AAB35990.1; -; mRNA. DR IPI; IPI00219089; -. DR IPI; IPI00294177; -. DR PIR; S25561; S25561. DR PIR; S32652; S32652. DR RefSeq; NP_002692.2; -. DR RefSeq; NP_976034.3; -. DR UniGene; Hs.249184; -. DR UniGene; Hs.632482; -. DR UniGene; Hs.646545; -. DR HSSP; P20263; 1OCP. DR IntAct; Q01860; 1. DR STRING; Q01860; -. DR PhosphoSite; Q01860; -. DR PRIDE; Q01860; -. DR Ensembl; ENST00000259915; ENSP00000259915; ENSG00000204531; Homo sapiens. DR Ensembl; ENST00000376243; ENSP00000365419; ENSG00000206454; Homo sapiens. DR Ensembl; ENST00000383524; ENSP00000373016; ENSG00000206454; Homo sapiens. DR Ensembl; ENST00000412166; ENSP00000387646; ENSG00000229094; Homo sapiens. DR Ensembl; ENST00000419095; ENSP00000413622; ENSG00000235068; Homo sapiens. DR Ensembl; ENST00000420806; ENSP00000405122; ENSG00000206454; Homo sapiens. DR Ensembl; ENST00000421399; ENSP00000413535; ENSG00000206454; Homo sapiens. DR Ensembl; ENST00000423782; ENSP00000398515; ENSG00000237582; Homo sapiens. DR Ensembl; ENST00000424624; ENSP00000403592; ENSG00000204531; Homo sapiens. DR Ensembl; ENST00000428184; ENSP00000388685; ENSG00000204531; Homo sapiens. DR Ensembl; ENST00000429233; ENSP00000391906; ENSG00000233911; Homo sapiens. DR Ensembl; ENST00000429314; ENSP00000387619; ENSG00000237582; Homo sapiens. DR Ensembl; ENST00000429603; ENSP00000392877; ENSG00000233911; Homo sapiens. DR Ensembl; ENST00000430678; ENSP00000401571; ENSG00000237582; Homo sapiens. DR Ensembl; ENST00000431280; ENSP00000393786; ENSG00000230336; Homo sapiens. DR Ensembl; ENST00000433063; ENSP00000405041; ENSG00000235068; Homo sapiens. DR Ensembl; ENST00000433348; ENSP00000412665; ENSG00000230336; Homo sapiens. DR Ensembl; ENST00000434616; ENSP00000388842; ENSG00000229094; Homo sapiens. DR Ensembl; ENST00000437747; ENSP00000391681; ENSG00000237582; Homo sapiens. DR Ensembl; ENST00000439404; ENSP00000402288; ENSG00000229094; Homo sapiens. DR Ensembl; ENST00000441888; ENSP00000389359; ENSG00000204531; Homo sapiens. DR Ensembl; ENST00000448286; ENSP00000400954; ENSG00000235068; Homo sapiens. DR Ensembl; ENST00000448657; ENSP00000416165; ENSG00000204531; Homo sapiens. DR Ensembl; ENST00000451077; ENSP00000391507; ENSG00000233911; Homo sapiens. DR Ensembl; ENST00000454714; ENSP00000400047; ENSG00000230336; Homo sapiens. DR GeneID; 5460; -. DR KEGG; hsa:5460; -. DR UCSC; uc003nsu.1; human. DR UCSC; uc003nsv.1; human. DR CTD; 5460; -. DR GeneCards; GC06M031240; -. DR H-InvDB; HIX0050476; -. DR H-InvDB; HIX0058021; -. DR H-InvDB; HIX0058196; -. DR HGNC; HGNC:9221; POU5F1. DR HPA; CAB025600; -. DR MIM; 164177; gene. DR PharmGKB; PA33545; -. DR HOVERGEN; Q01860; -. DR OMA; Q01860; LENMFLQ. DR NextBio; 21135; -. DR Bgee; Q01860; -. DR Genevestigator; Q01860; -. DR GermOnline; ENSG00000204531; Homo sapiens. DR GO; GO:0005737; C:cytoplasm; IDA:UniProtKB. DR GO; GO:0005634; C:nucleus; IDA:UniProtKB. DR GO; GO:0005515; F:protein binding; IPI:UniProtKB. DR GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro. DR GO; GO:0003700; F:transcription factor activity; IDA:HGNC. DR GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc. DR GO; GO:0006355; P:regulation of transcription, DNA-dependent; IDA:HGNC. DR GO; GO:0006350; P:transcription; IEA:UniProtKB-KW. DR InterPro; IPR001356; Homeobox. DR InterPro; IPR017970; Homeobox_CS. DR InterPro; IPR012287; Homeodomain-rel. DR InterPro; IPR013847; POU. DR InterPro; IPR015585; POU_dom_5. DR InterPro; IPR000327; POU_specific. DR Gene3D; G3DSA:1.10.10.60; Homeodomain-rel; 1. DR PANTHER; PTHR11636:SF15; POU_5; 1. DR Pfam; PF00046; Homeobox; 1. DR Pfam; PF00157; Pou; 1. DR PRINTS; PR00028; POUDOMAIN. DR ProDom; PD000010; Homeobox; 1. DR ProDom; PD000583; POU; 1. DR SMART; SM00389; HOX; 1. DR SMART; SM00352; POU; 1. DR PROSITE; PS00027; HOMEOBOX_1; 1. DR PROSITE; PS50071; HOMEOBOX_2; 1. DR PROSITE; PS00035; POU_1; 1. DR PROSITE; PS00465; POU_2; 1. DR PROSITE; PS51179; POU_3; 1. PE 1: Evidence at protein level; KW Alternative splicing; Complete proteome; DNA-binding; Homeobox; KW Isopeptide bond; Nucleus; Polymorphism; Transcription; KW Transcription regulation; Ubl conjugation. FT CHAIN 1 360 POU domain, class 5, transcription factor FT 1. FT /FTId=PRO_0000100747. FT DOMAIN 138 212 POU-specific. FT DNA_BIND 230 289 Homeobox. FT CROSSLNK 123 123 Glycyl lysine isopeptide (Lys-Gly) FT (interchain with G-Cter in SUMO) (By FT similarity). FT VAR_SEQ 1 135 MAGHLASDFAFSPPPGGGGDGPGGPEPGWVDPRTWLSFQGP FT PGGPGIGPGVGPGSEVWGIPPCPPPYEFCGGMAYCGPQVGV FT GLVPQGGLETSQPEGEAGVGVESNSDGASPEPCTVTPGAVK FT LEKEKLEQNPEE -> MHFYRLFLGATRRFLNPEWKGEIDN FT WCVYVLTSLLPFKIQ (in isoform B). FT /FTId=VSP_002333. FT VARIANT 226 226 L -> F (in dbSNP:rs1150767). FT /FTId=VAR_046203. FT VARIANT 322 322 T -> A. FT /FTId=VAR_003774. FT VARIANT 351 351 T -> I (in dbSNP:rs1061120). FT /FTId=VAR_046204. FT VARIANT 357 357 M -> L. FT /FTId=VAR_003775. FT CONFLICT 189 189 A -> G (in Ref. 7; CAA79974). FT CONFLICT 220 220 I -> T (in Ref. 7; CAA79974). FT CONFLICT 227 227 V -> L (in Ref. 7; CAA79974). FT CONFLICT 230 230 R -> G (in Ref. 7; CAA79975). FT CONFLICT 240 240 R -> Q (in Ref. 7; CAA79975). FT CONFLICT 251 251 Q -> R (in Ref. 7; CAA79975). FT CONFLICT 272 272 D -> DVVR (in Ref. 8; AAB35990). SQ SEQUENCE 360 AA; 38571 MW; 934C58DAEA0C535B CRC64; MAGHLASDFA FSPPPGGGGD GPGGPEPGWV DPRTWLSFQG PPGGPGIGPG VGPGSEVWGI PPCPPPYEFC GGMAYCGPQV GVGLVPQGGL ETSQPEGEAG VGVESNSDGA SPEPCTVTPG AVKLEKEKLE QNPEESQDIK ALQKELEQFA KLLKQKRITL GYTQADVGLT LGVLFGKVFS QTTICRFEAL QLSFKNMCKL RPLLQKWVEE ADNNENLQEI CKAETLVQAR KRKRTSIENR VRGNLENLFL QCPKPTLQQI SHIAQQLGLE KDVVRVWFCN RRQKGKRSSS DYAQREDFEA AGSPFSGGPV SFPLAPGPHF GTPGYGSPHF TALYSSVPFP EGEAFPPVSV TTLGSPMHSN //